{"task_id": "6ca10ead2a84c190", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 446/905)", "text": "ctions/rare-and-imported-pathogens-laboratory-ripl\n\n--- Page 452 ---\n438\nInfectious diseases\nEye disease\nConjunctivitis\nCommon in tropical areas. Vision is normal. Diff erentiation between common infec-\ntious causes is outlined in table 9.29.\nTable 9.29 Common causes of conjunctivitis\nCause\nSecretions\nFeatures\nTreatment\nBacterial\nPurulent\nRed and swollen\nTopical antibiotics for 5d\nViral\nWatery\n\u00b1 Corneal lesion\nSymptomatic\nTrachoma \n(chlamydial)\nMucopurulent\nFollicles and papillae on lid Azithromycin PO or topical \ntetracycline\nReproduced from Brent et al., Oxford Handbook of Tropical Medicine, 2014, with permission from Oxford \nUniversity Press.\nTrachoma\nLeading infectious cause of blindness worldwide: visual impairment/blindness in 1.9 \nmillion, 200 million at risk. Prevalence in endemic areas 60- 90% (Africa, Central and \nSouth America, Asia, Middle East). Caused by Chlamydia trachomatis. Human-to-\nhuman transmission with contact, or via \ufb02 ies which land on noses/eyes. Presenta-\ntion: Active infection causes purulent discharge and follicular in\ufb02 ammation of the \neyelid (\ufb01 g 9.47a)\ue003scarring (fig 9.47b)\ue003eyelids turn inwards (entropion) and irritate \nthe cornea (trichiasis) (fig 9.47c) leading to visual loss.\nTreatment: WHO public health strategy SAFE: surgery to treat blinding disease \n(trichiasis), antibiotics (azithromycin) to clear infection (mass administration in en-\ndemic areas through International Trachoma Initiative), facial cleanliness, environ-\nmental improvement with access to water and sanitation.12\nImmunosuppression and the eye\n  \n\u2022 Herpes zoster ophthalmicus:\nDue to reactivation of latent varicella zoster virus \n(p404) in the ophthalmic branch of the trigeminal \nnerve. \ue000 Risk of reactivation and ocular complications \nin immunosuppression: HIV, post-transplantation. \nPresentation: vesiculomacular skin rash and dysaes-\nthesia in ophthalmic division of the trigeminal nerve \n(\ufb01 g 9.48). Hutchinson\u2019s sign = lesion at tip/side of nose \nindicates involvement of nasociliary branch of V1 and \n\ue000chance of eye involvement. Complications: corneal \nopaci\ufb01 cation, uveitis, ocular nerve palsy, eyelid de-\nformity, optic neuritis, post-herpetic neuralgia. Can \nbe sight-threatening \ue018 recognition and urgent treatment \nare required. Diagnosis: clinical. Antibody staining/PCR of \nskin scrapings. Treatment: oral famciclovir/valacyclovir or \nsystemic aciclovir reduce complications if given within 72h \nof symptoms. Analgesia. If retinitis IV cidofovir \u00b1 intravit-\nreal ganciclovir or foscarnet.\n  \n\u2022 CMV retinitis:\nReactivation of CMV infection (p405). Presentation: \n\ufb02 oaters due to in\ufb02 ammatory cells in vitreous, \ufb02 ashing \nlights, scotomata, eye pain, visual loss. Peripheral lesions \nFig 9.48 Herpes zoster ophthalmicus.\n\u00a9MN Oxman , University of California.\nFig 9.49 CMV retinitis (moz-\nzarella pizza fundus).\n\u00a9Prof Trobe.\nFig 9.47 (a) Follicular trachoma. (b) Scarring. (c) Trichiasis.\nReproduced from Warrell et al., Oxford Textbook of Medicine, 2010, with permission from Oxford \nUniversity Press.\n(a)\n(b)\n(c)", "text_length": 3051, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 446/905)", "type": "chunk", "chunk_index": 445, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.938264", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.938950", "status": "complete", "chunks_added": 2}